Rehabilitation Institute of Chicago
USPTO PatentsView assignee record - 63 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Rehabilitation ranks #5,463 of 49,997 tracked US assignees by granted-patent volume, with 63 patents across 21 technology areas.
- #5,463
- of 49,997 US assignees by volume
- Top 27%
- by Innovation Score (43.9/100)
- 17.5
- avg claims per patent
- -28%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R5463 · US Corporation #5,463 · 63 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-SMALL 63 grants
- UPPER-Q #5,463/49,997
- PHOTO-FINISH Plexxikon
- CPC-FOCUS A61F · 21 areas
- INNOV-PAR 43.9/100
- CLAIMS-RICH 17.5 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -28% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Plexxikon Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Rehabilitation’s 43.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Rehabilitation
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Coulter Ventures · near
Coulter Ventures · near
44 score
- PME IP PTY · near
PME IP PTY · near
44 score
- Qingdao Haier Joint… · near
Qingdao Haier Joint… · near
44 score
- Rehabilitation… · this assignee
Rehabilitation… · this assignee
44 score
- Sorrento Therapeutics · near
Sorrento Therapeutics · near
44 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Rehabilitation's Innovation Score is 43.9/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Rehabilitation?
Each dot is one of Rehabilitation’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rehabilitation’s own 17.5 claims/patent is ABOVE the 11.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Rehabilitation's grants concentrate
Rehabilitation Institute of Chicago is a focused PatentsView assignee: 21 CPC subclasses with 50.8% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (18 grants) versus a trough of 1 in 2015. By volume, Rehabilitation sits between Plexxikon Inc. and SK Global Chemical Co., Ltd..
Rehabilitation's three-year grant acceleration
From 2019–2021 to 2022–2024, Rehabilitation Institute of Chicago moved from 31 to 13 grants (0.42x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Rehabilitation's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Plexxikon
Plexxikon Inc.
63 patents
- Purewick
PureWick Corporation
63 patents
- R A Brands L L C
R A Brands L.L.C.
63 patents
- Rockspoon
Rockspoon, Inc
63 patents
- Robert Bosch Auto…
Robert Bosch Automotive Steering LLC
63 patents
- Shanghai Universi…
Shanghai University
63 patents
- Shenzhen Eigate T…
Shenzhen Eigate Technology Co., Ltd.
63 patents
- SK Global Chemical
SK Global Chemical Co., Ltd.
63 patents
- Rehabilitation In… ◀
Rehabilitation Institute of Chicago
63 patents
What this shows Rehabilitation holds 63 patents at rank #5,464, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Rehabilitation
By rank, the assignees closest to #5,464 in granted patent volume.
- Plexxikon Inc. #5,460 · 63 patents
- PureWick Corporation #5,461 · 63 patents
- R A Brands L.L.C. #5,462 · 63 patents
- Rockspoon, Inc #5,463 · 63 patents
- Robert Bosch Automotive Steering LLC #5,465 · 63 patents
- Shanghai University #5,466 · 63 patents
- Shenzhen Eigate Technology Co., Ltd. #5,467 · 63 patents
- SK Global Chemical Co., Ltd. #5,468 · 63 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Rehabilitation's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Rehabilitation, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Rehabilitation ranks #197 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (44 here).
Similar claim depth
Nearest assignees by average claims per patent (17.5 here).
Rehabilitation's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 27% higher than 73% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 1.6% |
| 2016 | 1 | 1.6% |
| 2017 | 11 | 17.5% |
| 2018 | 5 | 7.9% |
| 2019 | 18 | 28.6% |
| 2020 | 9 | 14.3% |
| 2021 | 4 | 6.3% |
| 2022 | 6 | 9.5% |
| 2023 | 3 | 4.8% |
| 2024 | 4 | 6.3% |
| 2025partial year | 1 | 1.6% |
Which technologies does Rehabilitation Institute of Chicago patent most?
Top 15 of 21 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Rehabilitation Institute of Chicago's patent record in context - here's where to go next.
- Rehabilitation Institute of Chicago's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 50.8% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #5,463 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Rehabilitation Institute of Chicago against Plexxikon Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 43.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.